Company type
Insect-protein farming company.Overview
Nasekomo is a European scale-up dedicated to advancing insect bioconversion for sustainable high-quality protein production. Established in 2017, the biotechnology company is committed to addressing global agricultural challenges through innovative solutions, leveraging cutting-edge AI technologies, robotics and digitalized solutions. Through Fly Genetics, its joint venture with Groupe Grimaud, a world leader in animal genetics selection, it has developed a sophisticated selection program, empowering its partners to produce enhanced premium insect protein on an industrial scale. Rooted in its core activities, the company employs a circular model that has the potential to inspire and elevate sustainability practices across other industries.
Funding rounds
Series A EUR 8,000,000
( )
Funding "to launch an extensive network of cutting-edge insect bioconversion facilities across Europe, with an eye towards expanding onto additional continents in the near future."
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Invenio Partners | Initial investment. Led the round. |
Investment activity status
Active investor